Please login to the form below

Not currently logged in
Email:
Password:

pregabalin

This page shows the latest pregabalin news and features for those working in and with pharma, biotech and healthcare.

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

rival to Pfizer’s big-selling Lyrica (pregabalin) brand which brought in $4.7bn last year despite generic competition in some markets. ... The challenge for Daiichi Sankyo with mirogabalin will be positioning it as a realistic alternative to pregabalin

Latest news

More from news
Approximately 0 fully matching, plus 25 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics